Virginia Bio’s Post

Mesh Bio raises US$3.5 million of Series A funding led by East Ventures, to make its digital twin technologies available at scale Mesh Bio, a Singapore-based #digitalhealth startup focused on addressing the growing global clinical burden of #metabolicdiseases due to #aging population, and challenges in #caredelivery, announced that it has raised US$3.5 million in Series A financing. The funding will allow Mesh Bio to offer its #digitaltwin technologies to #healthcare providers and scale the deployment of these solutions across Hong Kong and Southeast Asia, mainly Indonesia and the Philippines. #digitalhealth  #digitalhealthstartup #Undesrtanddisease #Predicttrajectory #GuideIntervention #HumanDigitalTwin #ComputationalBiology Read on: https://lnkd.in/dMW6PReW

💰 Are you a #healthtech startup that's fundraising? Raising funds for #healthtech can be tough. In our experience many startups waste valuable time with investors unfamiliar with the health tech industry and its specific challenges and opportunities. We want to change this! That's why we created our new Investment Series: an event series connecting investors currently investing in, or actively considering #digitalhealth. We invite some of Denmark’s wealthiest family offices, prominent business angels, and key local and international venture funds to meet with a handpicked selection of health tech startups. Who can join? 🚀 Any startup that is working in the health tech space and fundraising currently/within the next 6-9 months can apply to get into consideration by Health Tech Hub Copenhagen. What do we offer? ⭐ We will connect you to our network of knowledgeable health tech investors searching for new investment opportunities. ⭐ To ensure the best results, we will help you prepare for the event by reviewing your pitch deck and providing investment-focused pitch training. How to apply: ➡ Apply for a seat here: https://lnkd.in/dQNyvSv6 (Participating companies will be selected by Health Tech Hub Copenhagen; terms and conditions apply) ❓ Want to know more? Reach out to Investment Manager Nicolas Bouchet! Jesper Grønbæk | Mafalda Camara | Jannik Topgaard Zeuthen | Oded Yair Menuhin | Line Knoop-Henriksen | Line Rasmussen | Giulia Galimberti | Martin Broch Pedersen | Anett Falussy | Elyse Courville

Organon, a global healthcare company dedicated to improving women’s health, in partnership with Flat6Labs, MENA’s leading seed and early-stage venture capital firm, is thrilled to announce the launch of the second cycle of the Women’s Health Accelerator Program. Building on the success of the inaugural cycle and the incredible momentum witnessed across the region, this initiative aims to empower digital health startups with solutions to enhance women’s health across the #MiddleEast, #NorthAfrica, and #Turkey (#MENAT) region. Organon’s goal is to be the leading women’s health company in the world by focusing on women’s everyday health needs. Organon is a global healthcare company formed through a spinoff from Merck (known as MSD outside of the #US. and #Canada) with a mission to deliver impactful medicines and solutions for a healthier every day. Flat6Labs Ragia Abdel Ghafour Sarah Hariz Organon MENAT (Middle East, North Africa, Turkey & Ukraine) To share your startup story write us on - contact@startuprise.org #Flat6Labs #Organon #WomensHealth #WomensWellness #Femtech #MENA #startups #healthtech

💰 Want to pitch your #healthtech startup to a room full of relevant investors? Could use expert help to sharpen you pitch and deck? Raising funds for #healthtech can be tough. In our experience many startups waste valuable time with investors unfamiliar with the health tech industry and its specific challenges and opportunities. We want to change this! That's why we created our new Investment Series: an event series connecting investors currently investing in, or actively considering #digitalhealth. We invite some of Denmark’s wealthiest family offices, prominent business angels, and key local and international venture funds to meet with a handpicked selection of health tech startups. ❗24 investors have already signed up! ❗ Who can join? 🚀 Any startup that is working in the health tech space and fundraising currently/within the next 6-9 months can apply to get into consideration by Health Tech Hub Copenhagen. What do we offer? ⭐ We will connect you to our network of knowledgeable health tech investors searching for new investment opportunities. ⭐ To ensure the best results, we will help you prepare for the event by reviewing your pitch deck and providing investment-focused pitch training. How to apply: ➡ Apply for a seat here: https://lnkd.in/dQNyvSv6 (Participating companies will be selected by Health Tech Hub Copenhagen; terms and conditions apply) ❓ Want to know more? Reach out to Investment Manager Nicolas Bouchet! Jesper Grønbæk | Mafalda Camara | Jannik Topgaard Zeuthen | Oded Yair Menuhin | Line Knoop-Henriksen | Line Rasmussen | Giulia Galimberti | Martin Broch Pedersen | Anett Falussy | Elyse Courville

#Startups receive priceless mentoring by former #pharma executives in PharmStars’ virtual #acceleratorprogram! 🎓Our Spring 2024 cohort graduate, Chrissa McFarlane, founder and CEO of Patientory, Inc. , shared how PharmStars helped her digital health startup identify and create a clear #pharma value proposition for her company’s sophisticated, digital offering. Chrissa said: “PharmStars commitment to excellence is well received and I couldn't have asked for better feedback and guidance throughout the process in expressing our complicated solution. I am truly grateful to have gone through the program!” 🌟 Don’t miss your chance to get personalized guidance on your pharma business model and value proposition from PharmStars’ Mentor Advisors. You will also have the opportunity to present to and meet with PharmStars’ pharma members. 🚀 Experience PharmStars' commitment to excellence for yourself. Apply to participate by July 15 at www.PharmStars.com! This cohort focuses on “Digital Innovations in Clinical Trials”! #venturecapital #Investment #entrepreneur #Investors #transformation #partnerships #businessdevelopment #bizdev #engagement #financing #funding #biopharma #healthcare #digitaltransformation #digitalinnovation #remotemonitoring #patientexperience #digital #innovation #digitalhealth #virtualtrials #accelerator #datacollection #RemotePatientMonitoring #RPM #datamanagement #VC #clinicaltrials #digitalhealth #startup

Ivory Coast-based e-health company 🇨🇮, Meditect is revolutionizing pharmacy management across Francophone Sub-Saharan Africa with its cutting-edge software. 🌍 📈 Active in eight countries, Meditect plans to expand into eight more by 2026, enhancing pharmacy operations and driving revenue growth. 💼 CEO, Arnaud Pourredon highlights their mission to provide top-tier software and customer experiences, generating valuable data for partners like NGOs and governments. 🚀 After navigating challenges and diverse markets, Meditect is accelerating growth with strategic funding from investors including LBO France, Dakar Network Angels (DNA), Proparco, and Launch Africa Ventures. 💥 With a SaaS model at EUR600/year and customized insights for stakeholders, Meditect is set to transform healthcare management in the region. Read more: https://lnkd.in/drSnFGpt #Africa #BusinessNews #Startup #Meditect #IvoryCoast #Growth #Healthcare

Europe stands to gain immensely from the establishment of Integrated Healthcare Innovation Ecosystems, fostering synergistic partnerships among Industry, Start-ups, Academia, and Government. Such collaborations are pivotal for Europe to compete in building industry around Healthcare innovation while benefitng from better patient outcomes, modernized healthcare delivery, and more efficiency & sustainability in health systems Roche Slovensko is honored to participate as a partner in the EIT Health Innovators Challenge-Based Acceleration program, aimed at nurturing nine promising European start-ups to propel their innovative solutions into the European healthcare landscape. It was truly gratifying to contribute insights on fostering constructive collaborations between pharmaceutical entities and start-ups. I wish the 9 start-ups participating in this accelerator a lot of success with their inspiring projects #healthcare #innovation #startups

🎉 Let's give a warm welcome to Zeynep Nisan Gündüz, the newest addition to the Earlybird Health Investment Team! Berlin-born and raised, Zeynep is no stranger to the local ecosystem and brings valuable experience to the table. She recently completed the Founder Associate Program at Atlantic Labs & FoodLabs, working alongside the founders of two early-stage healthcare startups apryl and Every Health. Zeynep has also undertaken visiting positions at Kry and Moss and is active in the 2hearts community. She holds a Master's in Impact Entrepreneurship and Innovation from Nova School of Business and Economics, and a Bachelor's in International Management from Freie Universität Berlin. Get to know her better in the Q&A below 👇 🧩 How does your background enable you to support the Earlybird Health Team? Over the past two years, I've worked closely with several founders, supporting their fundraising efforts and taking on various growth roles. Being in the trenches has helped me understand the challenges of healthcare companies - especially regulatory and operational hurdles - and has sharpened my ability to identify disruptive technologies. All of this has primed me not just to keep pace but to push boundaries and contribute to the success of Earlybird Health. 💡 What aspects of healthcare innovation excite you the most? I'm particularly fascinated by the potential of personalized medicine and real-time health data, as well as the broader impact of digital technologies in MedTech and biopharma. These advancements hold much promise to improve patient outcomes and make healthcare more tailored and accessible. As a strong advocate for shifting from reactive to proactive care, I believe in emphasizing early intervention. This transformative approach could revolutionize people's lives. 🧠 How do you stay informed about emerging healthcare trends and innovations? Primarily by talking to people, keeping the conversations with industry experts going, and also acknowledging that there will always be topics where my knowledge is not exhaustive. It’s a mix of staying open to learning, being curious, reading a lot, and tapping into the wealth of knowledge of the people surrounding me. For everyone interested in staying updated about the future trends in healthcare, I recommend the weekly newsletter from Bertalan Meskó, MD, PhD! Cc: Thom Rasche, John Yianni, Florent Gros, Lionel Carnot, Dr. Christoph Massner, Rabab Nasrallah, PhD, Junkai Z., Kian Rokni, Elena Marchesi #Healthcare #Investing #VC #Startups #Europe #EBVCteam

Any of my colleagues in the Italian ecosystem, please feel free to reach out to Francesca Lazzarin and our Italian team to join this great event. Topics include ☝ Why now for Italy? ↕ Tech Transfer 📖 The talent checklist ⚖ Start-up Life vs Corporate Life There are a few places remaining #LifeScience #StartUp #Investing #VC #PE

Introducing the LX Health Syndicate!🔥 We’re thrilled to partner with Aussie Angels to launch the LX Health Syndicate, dedicated to investing in the most promising HealthTech startups from the LuminaX Accelerator and more! First Deal Live: Bloody Good Tests 🩸🚀 Our first deal with Bloody Good Tests is now LIVE on the platform! We’re incredibly proud to continue supporting this fantastic team, Thor ⚡ B. and Ben Novakovic 🙌 The LX Health team are so excited to back companies that are making a difference to Australians' health - stay tuned for more deals coming soon!  🔗Link to join the syndicate and see deals here: https://lnkd.in/gwfTQdis Join us for free - no commitment required to invest. This is your chance to invest alongside us in smaller amounts, offering a flexible alternative to long-term fund commitments. *Note: For wholesale investors only. This is not financial advice - always seek independent financial advice tailored to your situation. #HealthTech #Innovation #AussieAngels #Syndicate #Startups Dren Xërxa Georgia Wyllie